Skip to content

Effectiveness of Transcranial Direct Current Stimulation (A brain stimulation technique) in treatment of Obsessive Compulsive Disorder.

Efficacy and Safety of add on Cathodal Transcranial Direct Current Stimulation (c-tDCS) over Pre- supplementary Motor Area (Pre-SMA) in Patients with Treatment-Resistant Obsessive Compulsive Disorder: A Randomized Sham-controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011845
Enrollment
40
Registered
2018-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Obsessive Compulsive Disorder

Interventions

Intervention1: Cathodal Transcranial Direct Current Stimulation (c-tDCS): Cathode will be placed over the pre-SMA and anode will be placed over the right deltoid. Total ten sessions of tDCS, two sessi

Sponsors

Department of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Obsessive Compulsive disorder according to ICD 10-DCR diagnostic criteria (F42) 2. Patients diagnosed with treatment resistant OCD defined as non-response to adequate trials (Adequate dose- 60 mg of Fluoxetine equivalent and adequate duration- 10-12 weeks) of at least 2 antiobsessive medications, with or without cognitive-behavioral therapy (CBT) 3. Giving written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with any other major neuropsychiatric disorder such as schizophrenia or bipolar affective disorder. 2. Patients with any major neurological disorder. 3.Patients with contraindications to tDCS (Metal implant in the head, pacemaker) 4. Patients who have been newly recruited for Cognitive Behavioural Therapy during the period of follow up. 5. Pregnancy

Design outcomes

Primary

MeasureTime frame
Reduction in absolute score in Yale- Brown Obsessive Compulsive Scale Stages of response defined as: Partial response- Greater than 25% but less than 35% Y-BOCS reduction, Full response- 35% or greater reduction of Y-BOCS and CGI 1 or 2, Remission- Less than 16 on Y-BOCS, Recovery- Less than 8 on Y-BOCSTimepoint: Baseline, after 10 sessions of tDCS, after 1 month, after 3 months

Secondary

MeasureTime frame
Assessment of safety of tDCS based on adverse effects questionnaireTimepoint: After each session of tDCS;Effect of tDCS on abstract ability and set shifting, decision making, response inhibition, mental speed, verbal working memory, sustained attention and focused attention based on Wisconsin card sorting test, Go/No-go task, Stroop test, Digit symbol test, Verbal n-back test, Digit vigilance test, Colour trails testTimepoint: Baseline, after 10 sessions of tDCS, after 1 month, after 3 months;Reduction in Hamilton Anxiety Rating Scale score after tDCSTimepoint: Baseline, after 10 sessions of tDCS, after 1 month, after 3 months;Reduction on Hamilton Depression Rating Scale score after tDCSTimepoint: Baseline, after 10 sessions of tDCS, after 1 month, after 3 months

Countries

India

Contacts

Public ContactDr Annesha Mukherjee

Kasturba Medical College, Manipal

samir.kp@manipal.edu8971026304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026